Search
Now showing items 1-10 of 44
-
Compatibility of medications during multi-infusion therapy: A controlled in vitro study on a multilumen infusion device
Anaesthesia, Critical Care & Pain Medicine, 2015, 34, 83-88Article dans une revue scientifique -
Enantioseparation and thermodynamic study of naphthalene derivatives, new melatoninergic agonists, on coated amylose [tris(S)-1phenylethylcarbamate] stationary phase. Transposition to preparative scale
Biomedical chromatography . BMC, 01-05-2015, 29, 689-697Article dans une revue scientifique -
Phase 1 study of the oral histone deacetylase inhibitor abexinostat in patients with Hodgkin lymphoma, non-Hodgkin lymphoma, or chronic lymphocytic leukaemia
Investigational new drugs, 21-01-2015, 33, 423-431Article dans une revue scientifique -
Mechanisms of Action of Lenalidomide in B-Cell Non-Hodgkin Lymphoma
Journal of clinical oncology, 09-2015, 33, 2803-U127Article dans une revue scientifique -
Reproducibility evaluation of Tc-99m-mebrofenin hepatobiliary scintigraphy using SPECT for future remnant liver functional assessment before major hepatectomy
Med. Nucl.-Imag. Fonct. Metab., 2015, 39, 182-191Article dans une revue scientifique -
Utility of (18)fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma
Annals of oncology, 26-04-2015, 26, 774-779Article dans une revue scientifiquefulltext -
Safety and activity of the anti-CD79B antibody-drug conjugate polatuzumab vedotin in relapsed or refractory B-cell non-Hodgkin lymphoma and chronic lymphocytic leukaemia: a phase 1 study
The Lancet. Oncology, 2015, 16, 704-715Article dans une revue scientifique -
Anti-CD22 and anti-CD79B antibody drug conjugates are active in different molecular diffuse large B-cell lymphoma subtypes
Leukemia, 2015, 29, 1578-1586Article dans une revue scientifique -
Radioimmunotherapy (Y-90-Ibritumomab Tiuxetan) for Posttransplant Lymphoproliferative Disorders After Prior Exposure to Rituximab
American journal of transplantation, 2015, 15, 1976-1981Article dans une revue scientifique -
An Open-Label, Multicenter, Phase I/II Study of JNJ-40346527, a CSF-1R Inhibitor, in Patients with Relapsed or Refractory Hodgkin Lymphoma
Clinical cancer research, 2015, 21, 1843-1850Article dans une revue scientifique